Dipeptidyl Peptidase-4 Inhibitors and Beta Cell Mass in Japanese Adults with Type 2 Diabetes

Endocr Pract. 2022 May;28(5):563-564. doi: 10.1016/j.eprac.2022.02.001. Epub 2022 Feb 7.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Diabetes Mellitus, Type 2* / drug therapy
  • Dipeptidyl-Peptidase IV Inhibitors* / therapeutic use
  • Dipeptidyl-Peptidases and Tripeptidyl-Peptidases
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Japan

Substances

  • Dipeptidyl-Peptidase IV Inhibitors
  • Hypoglycemic Agents
  • Dipeptidyl-Peptidases and Tripeptidyl-Peptidases